Author Details

Semiglazov, V F

Issue Section Title File
Vol 3, No 1 (2001) Articles Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya
Vol 5, No 3 (2003) Articles Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina)
Vol 5, No 4 (2003) Articles Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy
Vol 7, No 1 (2005) Articles Faktory prognoza pri rake molochnoy zhelezy
Vol 7, No 1 (2005) Articles Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy
Vol 7, No 2 (2005) Articles «Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Vol 9, No 2 (2007) Articles Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Vol 11, No 3 (2009) Articles Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Vol 15, No 4 (2013) Articles The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Vol 16, No 2 (2014) Articles Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Vol 16, No 4 (2014) Articles Male breast cancer: review of the literature
Vol 17, No 1 (2015) Articles The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council
Vol 17, No 1 (2015) Articles Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Vol 18, No 2 (2016) Articles New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies